| Literature DB >> 28042292 |
Mikito Inokuchi1, Sho Otsuki1, Norihito Ogawa1, Toshiro Tanioka1, Keisuke Okuno1, Kentaro Gokita1, Tatsuyuki Kawano1, Kazuyuki Kojima2.
Abstract
Background. Some meta-analyses of case-controlled studies (CCSs) have shown that laparoscopic or laparoscopy-assisted total gastrectomy (LTG) had some short-term advantages over open total gastrectomy (OTG). However, postoperative complications differed somewhat among the meta-analyses, and some CCSs included in the meta-analyses had mismatched factors between LTG and OTG. Methods. CCSs comparing postoperative complications between LTG and OTG were identified in PubMed and Embase. Studies matched for patients' status, tumor stage, and the extents of lymph-node dissection were included. Outcomes of interest, such as anastomotic, other intra-abdominal, wound, and pulmonary complications, were evaluated in a meta-analysis performed using Review Manager version 5.3 software. Result. This meta-analysis included a total of 2,560 patients (LTG, 1,073 patients; OTG, 1,487 patients) from 15 CCSs. Wound complications were significantly less frequent in LTG than in OTG (n = 2,430; odds ratio [OR] 0.30, 95% confidence interval [CI] 0.29-0.85, P = 0.01, I2 = 0%, and OR 0.46, 95% CI 0.17-0.52, P < 0.0001, I2 = 0%). However, the incidence of anastomotic complications was slightly but not significantly higher in LTG than in OTG (n = 2,560; OR 1.44, 95% CI 0.96-2.16, P = 0.08, I2 = 0%). Conclusion. LTG was associated with a lower incidence of wound-related postoperative complications than was OTG in this meta-analysis of CCSs; however, some concern remains about anastomotic problems associated with LTG.Entities:
Year: 2016 PMID: 28042292 PMCID: PMC5155090 DOI: 10.1155/2016/2617903
Source DB: PubMed Journal: Gastroenterol Res Pract ISSN: 1687-6121 Impact factor: 2.260
Figure 1Flowchart of study selection.
Quality assessment of CCSs based on the Newcastle-Ottawa scoring system.
| Selection | Comparability | Exposure | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Author | Year | Is the case definition adequate? | Representativeness of the cases | Selection of controls | Definition of controls | Comparability on the basis of the design or analysis | Ascertainment of exposure | Same method of ascertainment | Nonresponse rate |
| Kim et al. [ | 2008 |
|
|
|
|
|
| ||
| Topal et al. [ | 2008 |
|
|
|
|
|
| ||
| Kawamura et al. [ | 2009 |
|
|
|
|
|
| ||
| Kim et al. [ | 2011 |
|
|
|
|
|
| ||
| Siani et al. [ | 2012 |
|
|
|
|
|
| ||
| Bo et al. [ | 2013 |
|
|
|
|
|
| ||
| Guan et al. [ | 2013 |
|
|
|
|
|
| ||
| Hong et al. [ | 2013 |
|
|
|
|
|
| ||
| Kim et al. [ | 2013 |
|
|
|
|
|
| ||
| Kim et al. [ | 2013 |
|
|
|
|
|
| ||
| Lee et al. [ | 2013 |
|
|
|
|
|
| ||
| Shim et al. [ | 2013 |
|
|
|
|
|
| ||
| Lee et al. [ | 2014 |
|
|
|
|
|
| ||
| Lee et al. [ | 2015 |
|
|
|
|
|
| ||
| Ramagem et al. [ | 2015 |
|
|
|
|
|
| ||
CCSs, case-controlled studies. Select controls for patients' characteristics (age and gender) and clinical or pathological TNM classification.
Summary of the studies in this meta-analysis.
| Author | Published year | Duration of study |
| Tumor | Extent of LND | Including splenectomy | Type of reconstruction | Reported matching factor† |
|---|---|---|---|---|---|---|---|---|
| Kim et al. [ | 2008 | 2004–06 | 60 | pT1–3 | D1+/D2 | Yes | R-Y | 1,2, 3,5, 7 |
| Topal et al. [ | 2008 | 2003–06 | 60 | pStage I–IV | D2 | Yes | R-Y | 1,2, 3,4, 5,6, 7 |
| Kawamura et al. [ | 2009 | 2003–08 | 81 | cT1 | D2 | No | R-Y | 1,2, 3,4, 5,6, 7 |
| Kim et al. [ | 2011 | 2009–10 | 190 | cT1 | D2-No.10 | No | R-Y | 1,2, 3,4, 5,6, 7 |
| Siani et al. [ | 2012 | 2003–09 | 50 | pStage I–III | D1+/D2-No.10,11d | No | R-Y | 1,2, 5,6, 7 |
| Bo et al. [ | 2013 | 2004–10 | 234 | pT2-3 | D1+/D2-No.10,11d | No | R-Y | 1,2, 3,5, 6,7 |
| Guan et al. [ | 2013 | 2007–10 | 97 | cT1-2 | D2 | No | R-Y | 2,5, 6,7 |
| Hong et al. [ | 2013 | 2008–12 | 204 | pStage I–III | D2 | NR | NR | 1,2, 3,4, 5,6 |
| Kim et al. [ | 2013 | 2011 | 346 | cT1–3 N0-2 | D2-No.10 | No | R-Y | 1,2, 3,4, 5,6, 7 |
| Kim et al. [ | 2013 | 2002–10 | 120 | pSatge I–III | D1+/D2 | No | R-Y | 1,2, 3,4, 5,7 |
| Lee et al. [ | 2013 | 2003–10 | 100 | pStage I–IV | D1+ | No | R-Y | 1,2, 3,4, 5,6, 7 |
| Shim et al. [ | 2013 | 2009–11 | 70 | NR | D1+/D2 | NR | R-Y | 1,2, 7 |
| Lee et al. [ | 2014 | 2006–09 | 84 | cT1–3 | D2-No.10,11d | No | R-Y | 1,2, 5,6, 7 |
| Lee et al. [ | 2015 | 2003–10 | 753 | pT1 | D1+ | No | R-Y | 1,2, 3,4, 5,6, 7 |
| Ramagem et al. [ | 2015 | 2009–13 | 111 | pStage I–III | D2 | Yes | NR | 1,2, 3,4, 5,6 |
LND, lymph node dissection; PSM, propensity score matching; R-Y; Roux-en-Y; NR, not reported.
†Factors showing no significant statistical difference between LTG and OTG: 1, age; 2, gender; 3, body mass index; 4, comorbidity or American Society of Anesthesiologists physical status; 5, clinical or pathological TNM classification; 6, extent of lymphadenectomy; 7, type of reconstruction. Some studies did not show statistical differences in several factors.
Based on the 6th version of TNM classification. Based on the 7th version of TNM classification.
Figure 2(a) Comparison of anastomotic complications between LTG and OTG. (b) Comparison of other intra-abdominal complications between LTG and OTG. (c) Comparison of wound complications between LTG and OTG. (d) Comparison of pulmonary complications between LTG and OTG. (e) Comparison of mortality between LTG and OTG.